◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

USANA HEALTH SCIENCES INC

CIK: 896264 SIC: 2833
$925.26M
Revenue
$10.76M
Net Income
78.29%
Gross Margin
4.05%
Op. Margin
$41.08M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 15 annual reports available (2011 - 2025)
Breakdown TTM
(Jan 03, 2026)
FY 2025
(Jan 03, 2026)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $925.26M $925.26M $854.50M $921.01M $998.60M $1.19B
Revenue Growth % 0.0% 8.3% -7.2% -7.8% -15.8% nan%
Cost of Revenue $200.85M $200.85M $161.21M $176.69M $193.89M $217.90M
+ Gross Profit $724.40M $724.40M $693.29M $744.32M $804.71M $968.57M
Gross Margin % 78.3% 78.3% 81.1% 80.8% 80.6% 81.6%
Operating Expenses $686.97M $686.97M $626.97M $651.25M $697.10M $798.37M
Research & Development - $10.69M - - - -
Selling General & Admin $337.37M $337.37M $263.27M $256.99M $262.30M $279.11M
+ Operating Income $37.43M $37.43M $66.32M $93.07M $107.61M $170.19M
Operating Margin % 4.0% 4.0% 7.8% 10.1% 10.8% 14.3%
Interest Expense $1.38M $663.00K $76.00K $262.00K $192.00K $57.00K
Interest Income $2.42M $2.42M $11.32M $9.64M $3.79M $2.52M
Other Income/Expense $2.52M $2.52M $-1.01M $7.00K $-2.59M $-2.01M
Income Before Tax $41.53M $41.53M $76.35M $102.45M $108.62M $170.64M
Income Tax Expense $30.05M $30.05M $34.29M $38.66M $39.27M $54.14M
+ Net Income $10.76M $10.76M $42.03M $63.79M $69.35M $116.50M
Net Margin % 1.2% 1.2% 4.9% 6.9% 6.9% 9.8%
Basic EPS nan 0.58 2.20 3.31 3.60 5.78
Diluted EPS nan 0.58 2.19 3.30 3.59 5.73
Basic Shares Outstanding -83K 18.5M 19.1M 19.2M 19.3M 20.1M
Diluted Shares Outstanding -97K 18.6M 19.2M 19.3M 19.3M 20.3M
Breakdown FY 2025
(Jan 03, 2026)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $158.38M $181.77M $330.42M $288.42M $239.83M
Inventory $102.61M $69.73M $61.45M $67.09M $98.32M
Other Current Assets $4.85M $27.68M $25.87M $28.87M $26.97M
Total Current Assets $288.40M $279.19M $417.75M $384.38M $365.12M
Property Plant & Equipment $94.38M $94.56M $99.81M $97.77M $101.78M
Goodwill $137.96M $144.17M $17.10M $17.37M $17.67M
Intangible Assets $133.15M $151.82M $29.92M $32.43M $30.44M
Other Non-current Assets $61.80M $58.81M $54.89M $54.80M $57.89M
Total Assets $742.91M $748.19M $632.76M $596.55M $577.74M
Accounts Payable $17.26M $11.98M $10.07M $11.05M $13.51M
Accrued Liabilities $9.50M - - - -
Deferred Revenue $10.64M - - - -
Other Current Liabilities $97.30M $104.64M $107.99M $132.78M $147.28M
Total Current Liabilities $128.56M $139.62M $118.84M $143.83M $160.79M
Deferred Tax Liabilities $4.89M $4.07M $4.55M $4.07M $7.50M
Other Non-current Liabilities $23.19M $18.16M $12.16M $14.17M $14.33M
Total Liabilities $156.64M $161.86M $135.56M - -
Common Stock $18.00K $19.00K $19.00K $19.00K $19.00K
Retained Earnings $465.72M $478.94M $445.22M $391.64M $344.64M
Total Stockholders Equity $533.10M $532.11M $497.20M $434.47M $395.12M
Total Liabilities & Equity $742.91M $748.19M $632.76M $596.55M $577.74M
Breakdown TTM
(Jan 03, 2026)
FY 2025
(Jan 03, 2026)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $10.76M $10.76M $42.03M $63.79M $69.35M $116.50M
Depreciation & Amortization $40.90M $32.56M $14.54M $12.70M $13.39M $13.04M
Stock-based Compensation $23.21M $13.83M $14.56M $14.60M $13.33M $14.30M
Deferred Income Tax - $-7.14M - - - -
Change in Inventory $52.59M $34.69M $2.12M $-2.35M $-21.88M $10.50M
Change in Payables $12.99M $5.20M $-1.27M $-428.00K $-2.66M $-4.57M
Operating Cash Flow $65.53M $22.35M $60.99M $70.64M $103.90M $121.23M
Capital Expenditure $24.46M $13.82M $10.07M $14.49M $10.40M $12.76M
Acquisitions - - $203.34M - $6.53M -
Investing Cash Flow $-22.04M $-10.12M $-213.09M $-11.97M $-12.37M $-14.19M
Stock Repurchased $67.31M $27.51M $9.44M $11.60M $25.38M $177.84M
Financing Cash Flow $-108.15M $-40.60M $9.55M $-14.24M $-30.09M $-181.41M
Net Change in Cash $-55.79M $-23.27M $-148.74M $41.93M $47.67M $-72.28M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $213.67M $200.22M $699.06M $640.89M
Cost of Revenue $48.81M $39.26M $151.44M $122.66M
Gross Profit $164.85M $160.96M $547.61M $518.23M
Operating Expenses $163.63M $145.36M $514.00M $460.12M
Selling General & Admin $85.95M $61.30M $259.29M $189.92M
Operating Income $1.22M $15.60M $33.61M $58.11M
Interest Expense $49.00K $49.00K $662.00K $73.00K
Interest Income $578.00K $3.14M $1.92M $8.58M
Other Income/Expense $41.00K $-86.00K $2.54M $-621.00K
Income Before Tax $1.79M $18.61M $37.35M $65.92M
Income Tax Expense $8.46M $8.00M $24.28M $28.35M
Net Income $-6.52M $10.61M $12.54M $37.58M
Basic EPS -0.36 0.56 0.67 1.97
Diluted EPS -0.36 0.56 0.67 1.96
Basic Shares Outstanding $18.29M $19.08M $18.62M $19.11M
Diluted Shares Outstanding $18.29M $19.08M $18.67M $19.18M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $145.35M $181.77M
Inventory $90.78M $69.73M
Other Current Assets $27.93M $27.68M
Total Current Assets $264.06M $279.19M
Property Plant & Equipment $96.21M $94.56M
Goodwill $144.29M $144.17M
Intangible Assets $138.16M $151.82M
Other Non-current Assets $59.71M $58.81M
Total Assets $726.59M $748.19M
Accounts Payable $16.22M $11.98M
Other Current Liabilities $102.44M $104.64M
Total Current Liabilities $118.66M $139.62M
Deferred Tax Liabilities $4.47M $4.07M
Other Non-current Liabilities $21.91M $18.16M
Total Liabilities $145.04M $161.86M
Common Stock $18.00K $19.00K
Retained Earnings $467.50M $478.94M
Total Stockholders Equity $528.07M $532.11M
Total Liabilities & Equity $726.59M $748.19M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-6.52M $10.61M $12.54M $37.58M
Depreciation & Amortization $7.92M $3.57M $24.00M $10.54M
Stock-based Compensation - - $10.08M $10.95M
Change in Inventory - - $21.14M $3.79M
Change in Payables - - $4.13M $-3.04M
Operating Cash Flow - - $25.74M $55.21M
Capital Expenditure - - $11.03M $8.27M
Investing Cash Flow - - $-11.23M $-7.95M
Stock Repurchased - - $27.51M $9.44M
Financing Cash Flow - - $-54.06M $-13.38M
Net Change in Cash - - $-36.35M $34.49M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...